Poster Preview: ASCP 2024
Attending the 2024 ASCP Annual Meeting? Be sure to catch these upcoming poster presentations.
Source: psychiatrictimes.com
Agitation Associated News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Agitation Associated. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Agitation Associated Today - Breaking & Trending Today
IGC Pharma : Announces Positive Interim Results for IGC-AD1 in - Form 8-K -April 05, 2024 at 11:36 am EDT
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer's Agitation - Interim Data: Study Achieves Primary End Point Demonstrating...
Source: marketscreener.com
JAMA Neurology Publishes Complete Results of Positive Phase 3 Study of REXULTI® (brexpiprazole) for
New efficacy data reported for pivotal Study 213 shows significant, clinically meaningful improvements in agitation symptoms.Agitation symptoms negatively impact functioning, disease progression, quality of life and care for about half of Alzheimer’s dementia patients – and are a consistent predictor of nursing home...
Source: pharmiweb.com
BioXcel Therapeutics Receives Permanent J-Code for IGALMI™ (dexmedetomidine) Sublingual Film from Centers for Medicare & Medicaid Services
Standardizes and improves product reimbursement process New HCPCS Level II code J1105 to be effective January 1, 2024 NEW HAVEN, Conn., Oct. 30, 2023 -- BioXcel Therapeutics, Inc. , a...
Source: marketscreener.com
BioXcel Therapeutics Provides Update on Recent Developments for Late-Stage Clinical Programs and Expansion of IP Portfolio for IGALMI™ (dexmedetomidine) Sublingual Film
Meetings scheduled with FDA in October and November for TRANQUILITY and SERENITY III programs Company strengthens IGALMI™ market exclusivity through receipt of two Notices of Allowance ...
Source: marketscreener.com